Symbotic (NASDAQ: SYM) — A Pullback Creates an Opportunity in Warehouse Automation
Symbotic (NASDAQ: SYM) trades around $45 after a sharp decline that has pushed shares to their lowest levels of 2026. While the selloff has attracted attention, we believe the underlying business continues to move in the right direction.
The company develops AI-powered robotic systems that automate warehouses and distribution centers, serving a market that continues to grow as businesses look for greater efficiency throughout their supply chains.
What makes the recent weakness interesting is that it came despite solid operating results.
In its most recent quarter, Symbotic grew revenue 23% year over year and generated net income of $9 million, compared to a loss of $10 million during the same period a year earlier. The company is also rapidly expanding its deployment footprint, growing from 46 active systems in May 2025 to 70 systems as of May 2026.
The market appeared disappointed by earnings per share, which came in lower than some investors had hoped. However, we think it’s important to remember that deploying large-scale automation systems requires significant upfront investment. Those deployment costs can temporarily pressure profitability even as the business expands.
The bigger driver behind the stock’s decline may have been a large institutional sale.
On May 27, an investment vehicle affiliated with SoftBank sold approximately 5.59 million shares at $50.41 per share. The transaction weighed heavily on sentiment and pushed the stock lower.
We don’t view that sale as a sign that something is fundamentally wrong with the business.
Large institutional investors frequently rebalance positions, take profits, or recycle capital into new opportunities. Importantly, SoftBank still owns roughly 31.3% of Symbotic and continues to maintain a joint venture with the company focused on warehouse-as-a-service offerings.
Meanwhile, the company’s backlog remains impressive.
Symbotic reported a backlog of $22.7 billion, roughly 10 times its fiscal 2025 revenue. That provides substantial visibility into future growth and suggests demand remains strong.
The customer base also continues to expand. In April, Symbotic signed Medline as its first healthcare customer, extending its reach beyond retail and adding a new growth vertical alongside existing customers such as Walmart and Target.
For us, the investment case comes down to a simple question: has the long-term growth story changed?
Based on the information available, the answer appears to be no. Revenue is growing, profitability is improving, deployments are increasing, the backlog remains enormous, and the company is entering new markets.
The stock may continue to be volatile, but for investors who believe warehouse automation remains a major long-term trend, the recent pullback could present an attractive opportunity to build a position.
